Huntsman Cancer Institute joins innovative clinical trials program for blood cancers

Marker’s T cell therapy has shown potential in identifying and killing cancer cells. Credit: NICHD/J. Lippincott-Schwartz / Flickr (Creative Commons). Marker Therapeutics has reached a

The updated 2023-2024 COVID-19 vaccine was approximately 54% effective against symptomatic SARS-CoV-2 infection in adults, and was also effective against the JN.1 variant, which became

Eli Lil­ly’s tirzepatide has been ap­proved for weight man­age­ment in Chi­na, en­ter­ing what’s ex­pect­ed to be a sub­stan­tial mar­ket for GLP-1s. Tirzepatide — mar­ket­ed in